Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma is the second most common skin cancer in the United States. Currently, there is no standardized management approach for patients with cutaneous squamous cell carcinoma who develop metastatic or locally advanced disease and are not candidates for curative surgery or...
Guardado en:
Autores principales: | Guilherme Rabinowits, Michael R. Migden, Todd E. Schlesinger, Robert L. Ferris, Morganna Freeman, Valerie Guild, Shlomo Koyfman, Anna C. Pavlick, Neil Swanson, Gregory T. Wolf, Scott M. Dinehart |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7bfa396119cd430f85368f3066722ea1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
por: Nader Aboul-Fettouh, et al.
Publicado: (2021) -
Photoplethysmography for demarcation of cutaneous squamous cell carcinoma
por: Simon Mylius Rasmussen, et al.
Publicado: (2021) -
Recommendations for managing cutaneous disorders associated with advancing age
por: Humbert P, et al.
Publicado: (2016) -
Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma
por: Alesha A. Thai, et al.
Publicado: (2021) -
The landscape of driver mutations in cutaneous squamous cell carcinoma
por: Darwin Chang, et al.
Publicado: (2021)